Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin effects on CYP2D6 activity in adolescents
NCT03076021Phase 4Completed
- Sponsor
- University of Washington
- Start
- Jul 2016
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of isotretinoin in acne vulgaris, sponsored by University of Washington. Primary endpoint: CYP2D6 Activity as Measured by the Molar Concentration Ratio of Dextromethorphan (DM)/Dextrophan (DX). Started Jul 2016; status: completed.
02
Drugs
isotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03076021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03076021.